Ron D. Jachimowicz

Ron D. Jachimowicz is a Max Planck Research Group Leader specializing in DNA repair mechanisms and their relationship to aging and cancer development. As a Privatdozent (equivalent to Associate Professor), he leads an independent research group at the Max Planck Institute focused on understanding how DNA repair pathways impact genome stability, aging processes, and cancer progression. His work bridges basic science with clinical applications, particularly in lymphoma research.

Dr. Jachimowicz's research centers on the critical relationship between DNA repair mechanisms and aging. His group investigates defects in DNA repair pathways in patients with genome instability syndromes and in patients suffering from mantle cell lymphoma, utilizing an interdisciplinary approach that combines biochemistry, cell biology, computational biology, and mouse genetics. Key research areas include the role of UBQLN4 in DNA repair pathway choice, ATM signaling in DNA damage response, and the connection between genome maintenance defects and age-related diseases. His work has revealed important mechanisms linking DNA repair deficiencies to cancer development, particularly in lymphomas, and has identified potential therapeutic targets for cancer treatment.

Analysis of Dr. Jachimowicz's publication record shows a consistent focus on DNA repair mechanisms and their implications for cancer biology. His research demonstrates how defects in DNA repair pathways lead to genome instability, which drives both aging processes and cancer development. Recent publications highlight his work on UBQLN4's role in DNA repair pathway choice, ATM signaling in immune surveillance of lymphoma, and the development of targeted therapies for cancers with specific DNA repair deficiencies. His interdisciplinary approach combines molecular biology, mouse models, and clinical data to translate basic discoveries into potential therapeutic strategies.

Scientific Awards:

• Theodor Frerichs Prize from the German Society for Internal Medicine (DGIM), 2020

Dr. Jachimowicz serves as principal investigator for multiple significant research grants and advises doctoral students in his laboratory. His research is supported by prestigious funding including the German Research Foundation (DFG) Research Unit FOR5504 (2023-2026), Collaborative Research Center SFB1530 (2022-2025), and the Research Network CANTAR from the Ministry of Culture and Science of North Rhine-Westphalia (2022-2026). He also serves as co-speaker for the Else Kröner Research College on Clonal Evolution in Cancer. His doctoral student Julia Hansen received a scholarship from the German Academic Scholarship Foundation in 2022.

Dr. Jachimowicz leads a dynamic research laboratory focused on DNA repair mechanisms and their relationship to aging and cancer. His group employs a comprehensive interdisciplinary approach that integrates biochemical, cellular, computational, and genetic techniques to investigate how defects in DNA repair pathways contribute to genome instability syndromes and cancer development. The lab's work has particular relevance for understanding mantle cell lymphoma and developing targeted therapeutic interventions based on DNA repair deficiencies.